• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性硬脑膜下血肿的发病率:老龄化人口影响的单中心探讨及文献复习。

Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature.

机构信息

University Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.

Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.

出版信息

Acta Neurochir (Wien). 2021 Sep;163(9):2629-2637. doi: 10.1007/s00701-021-04879-z. Epub 2021 Jun 28.

DOI:10.1007/s00701-021-04879-z
PMID:34181085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8357776/
Abstract

BACKGROUND

Chronic subdural haematoma (cSDH) is a common neurosurgical pathology frequently occurring in older patients. The impact of population ageing on cSDH caseload has not been examined, despite relevance for health system planning.

METHODS

This is a single-centre study from the UK. Operated cases of cSDH (n = 446) for 2015-2018 were identified. Crude and directly standardised incidence rates were calculated. Medline and EMBASE were systematically searched to identify studies reporting on the incidence of cSDH by year, so an estimate of rate of incidence change could be determined. Local incidence rates were then applied to population projections for local catchment area to estimate operated cSDH numbers at 5 yearly intervals due to shifting demographics.

RESULTS

We identified nine studies presenting incidence estimates. Crude estimates for operative cases ranged from 1.3/100,000/year (1.4-2.2) to 5.3/100,000/year (4.3-6.6). When non-operated cases were included, incidence was higher: 8.2/100,000/year (6.0-11.2) to 48/100,000/year (37.7-61.1). Four pairs of studies demonstrated incidence rate increases of 200-600% over the last 50 years, but data was deemed too heterogeneous to generate formal estimate of incidence change. Local crude incidence of operated cSDH was 3.50/100,000/year (3.19-3.85). Directly standardised incidence was 1.58/100,000/year (1.26-1.90). After applying local incidence rates to population projections, case numbers were predicted to increase by 53% over the next 20 years.

CONCLUSIONS

The incidence of cSDH is increasing. We project a 53% increase in operative caseload within our region by 2040. These are important findings for guiding future healthcare planning.

摘要

背景

慢性硬脑膜下血肿(cSDH)是一种常见的神经外科疾病,常发生于老年患者。尽管对卫生系统规划具有重要意义,但人口老龄化对 cSDH 发病情况的影响尚未得到研究。

方法

这是一项来自英国的单中心研究。确定了 2015 年至 2018 年接受手术治疗的 cSDH(n=446)病例。计算了粗发病率和直接标准化发病率。系统检索了 Medline 和 EMBASE,以确定按年份报告 cSDH 发病率的研究,从而确定发病率变化的估计值。然后将当地发病率应用于当地集水区的人口预测,以估计由于人口结构变化导致的每 5 年间隔的手术治疗 cSDH 数量。

结果

我们确定了 9 项报告发病率估计的研究。手术治疗病例的粗发病率范围为 1.3/100,000/年(1.4-2.2)至 5.3/100,000/年(4.3-6.6)。当包括非手术治疗病例时,发病率更高:8.2/100,000/年(6.0-11.2)至 48/100,000/年(37.7-61.1)。四对研究表明,在过去 50 年中,发病率增加了 200-600%,但数据差异太大,无法生成发病率变化的正式估计值。当地手术治疗 cSDH 的粗发病率为 3.50/100,000/年(3.19-3.85)。直接标准化发病率为 1.58/100,000/年(1.26-1.90)。将当地发病率应用于人口预测后,预计未来 20 年内该地区的病例数将增加 53%。

结论

cSDH 的发病率正在增加。我们预计到 2040 年,该地区手术治疗的病例数将增加 53%。这些发现对指导未来的医疗保健规划具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93f/8357776/5a4b714b89c2/701_2021_4879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93f/8357776/b3f3a9f863c9/701_2021_4879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93f/8357776/5a4b714b89c2/701_2021_4879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93f/8357776/b3f3a9f863c9/701_2021_4879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93f/8357776/5a4b714b89c2/701_2021_4879_Fig2_HTML.jpg

相似文献

1
Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature.慢性硬脑膜下血肿的发病率:老龄化人口影响的单中心探讨及文献复习。
Acta Neurochir (Wien). 2021 Sep;163(9):2629-2637. doi: 10.1007/s00701-021-04879-z. Epub 2021 Jun 28.
2
Incidence of surgery for chronic subdural hematoma in Finland during 1997-2014: a nationwide study.1997-2014 年芬兰慢性硬脑膜下血肿手术发病率:一项全国性研究。
J Neurosurg. 2021 Sep 10;136(4):1186-1193. doi: 10.3171/2021.3.JNS21281. Print 2022 Apr 1.
3
Chronic subdural hematoma-incidence, complications, and financial impact.慢性硬脑膜下血肿——发病率、并发症和经济影响。
Acta Neurochir (Wien). 2020 Sep;162(9):2033-2043. doi: 10.1007/s00701-020-04398-3. Epub 2020 Jun 10.
4
Increasing incidence of chronic subdural haematoma in the elderly.老年人慢性硬膜下血肿发病率增高。
QJM. 2017 Jun 1;110(6):375-378. doi: 10.1093/qjmed/hcw231.
5
Predictors of recurrence of chronic subdural haematoma in a cohort study of patients presenting in a sub-Saharan African teaching hospital.在撒哈拉以南非洲教学医院就诊的患者队列研究中,预测慢性硬脑膜下血肿复发的因素。
BMC Neurol. 2022 Sep 14;22(1):346. doi: 10.1186/s12883-022-02857-1.
6
Chronic subdural haematoma associated with disturbance of consciousness: significance of acute-on-chronic subdural haematoma.与意识障碍相关的慢性硬膜下血肿:慢性硬膜下血肿急性发作的意义。
Neurol Res. 2015 Nov;37(11):985-92. doi: 10.1179/1743132815Y.0000000083. Epub 2015 Sep 7.
7
Assessing the accuracy of the International Classification of Disease (ICD) framework in the identification of patients with chronic subdural haematoma from hospital records.评估国际疾病分类(ICD)框架在从医院记录中识别慢性硬脑膜下血肿患者的准确性。
Surgeon. 2023 Oct;21(5):e271-e278. doi: 10.1016/j.surge.2023.02.001. Epub 2023 Mar 24.
8
COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.COXIBRAIN:慢性硬膜下血肿患者选择性COX-2抑制的前瞻性、随机、II/III期研究结果
Acta Neurochir (Wien). 2016 Nov;158(11):2039-2044. doi: 10.1007/s00701-016-2949-3. Epub 2016 Sep 7.
9
The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom.《慢性硬脑膜下血肿患者的管理和结局:英国一项前瞻性、多中心、观察性队列研究》。
J Neurosurg. 2017 Oct;127(4):732-739. doi: 10.3171/2016.8.JNS16134. Epub 2016 Nov 11.
10
Prevalence of and risk factors for recurrence of chronic subdural hematoma.慢性硬膜下血肿的复发率及危险因素
Acta Neurochir (Wien). 2018 May;160(5):893-899. doi: 10.1007/s00701-018-3513-0. Epub 2018 Mar 12.

引用本文的文献

1
Adjunctive role of middle meningeal artery embolization in patients with surgical treatment of unilateral chronic subdural hematoma: a systematic review and meta-analysis of randomized controlled trials.脑膜中动脉栓塞术在单侧慢性硬膜下血肿手术治疗患者中的辅助作用:一项随机对照试验的系统评价和荟萃分析
Front Surg. 2025 Jul 25;12:1623619. doi: 10.3389/fsurg.2025.1623619. eCollection 2025.
2
Efficacy of atorvastatin-based treatment in super-aged patients with chronic subdural hematoma: a case series and literature review.阿托伐他汀治疗高龄慢性硬膜下血肿患者的疗效:病例系列研究与文献综述
Front Neurol. 2025 Jun 27;16:1609514. doi: 10.3389/fneur.2025.1609514. eCollection 2025.
3

本文引用的文献

1
Chronic subdural haematoma in the elderly--a North Wales experience.老年人慢性硬膜下血肿——北威尔士的经验
J R Soc Med. 2002 Jun;95(6):290-2. doi: 10.1258/jrsm.95.6.290.
Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis of three randomized controlled trials and review of ongoing trials.
慢性硬膜下血肿的脑膜中动脉栓塞术:三项随机对照试验的荟萃分析及正在进行的试验综述
Acta Neurochir (Wien). 2025 Jun 10;167(1):166. doi: 10.1007/s00701-025-06587-4.
4
What happens to conservatively managed chronic subdural haematoma.保守治疗的慢性硬膜下血肿会怎样。
Acta Neurochir (Wien). 2025 Jun 7;167(1):164. doi: 10.1007/s00701-025-06577-6.
5
Middle Meningeal Artery Embolization Does Not Confer Protection against Symptomatic Recurrence in Patients with Early Antithrombotic Therapy Following Surgery for Chronic Subdural Hematomas.对于慢性硬膜下血肿手术后接受早期抗血栓治疗的患者,脑膜中动脉栓塞并不能预防症状性复发。
J Neuroendovasc Ther. 2025;19(1). doi: 10.5797/jnet.oa.2025-0013. Epub 2025 May 15.
6
Characteristics of chronic subdural haematomas related to DOACs vs warfarin.与直接口服抗凝剂(DOACs)和华法林相关的慢性硬膜下血肿的特征
BMC Neurol. 2025 Apr 26;25(1):184. doi: 10.1186/s12883-025-04134-3.
7
Clinical outcome of subdural versus subgaleal drain after burr-hole drainage for chronic subdural hematoma.颅骨钻孔引流术后慢性硬脑膜下血肿行颅骨下与帽状腱膜下引流的临床转归。
Acta Neurochir (Wien). 2024 Nov 1;166(1):433. doi: 10.1007/s00701-024-06320-7.
8
The impact of renin-angiotensin-aldosterone system inhibitors on the recurrence of chronic subdural hematoma: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统抑制剂对慢性硬脑膜下血肿复发的影响:系统评价和荟萃分析。
Neurosurg Rev. 2024 Oct 24;47(1):818. doi: 10.1007/s10143-024-03068-7.
9
Challenges and patient outcomes in chronic subdural haematoma at the level of a regional care system A multi-centre, mixed-methods study from the East of England.在区域医疗体系层面治疗慢性硬脑膜下血肿所面临的挑战及患者预后:一项来自英格兰东部的多中心混合方法研究。
Age Ageing. 2024 Apr 1;53(4). doi: 10.1093/ageing/afae076.
10
Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma.慢性硬膜下血肿患者护理多学科临床实践指南制定方案。
Wellcome Open Res. 2023 Sep 1;8:390. doi: 10.12688/wellcomeopenres.18478.1. eCollection 2023.